About 4 results found for searched term "PAD4-IN-2" (0.125 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M41728 | PAD4-IN-2 | PAD |
| PAD4-IN-2 is a PAD4 inhibitor (IC50=1.94 μM). | ||
| M6297 | Upadacitinib | JAK |
| ABT-494 | ||
| Upadacitinib (ABT-494) is a potent, orally active and selective Janus kinase 1 (JAK1) inhibitor (IC50=43 nM). Upadacitinib (ABT-494) displays approximately 74 fold selective for JAK1 over JAK2 (200 nM) in cellular assays dependent on specific, relevant cytokines. Upadacitinib (ABT-494) can be used for several autoimmune disorders research. | ||
| M10191 | Vipadenant | Adenosine Receptor |
| BIIB014; CEB-4520 | ||
| Vipadenant, also known as BIIB014, CEB-4520, is a potent, selective and orally available adenosine A2A receptor antagonist with Ki of 1.3 nM. | ||
| M19974 | GSK199 hydrochloride | PAD |
| GSK199 hydrochloride is a selective PAD4 inhibitor with half-maximum inhibitory concentration (IC50) values, in the absence of calcium, of 200 nM. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
